UCB Patient Support Programs

General resource-navigation contact for the medicines listed on the assistance page. Program staff must confirm individual support options. This route does not establish BRIVIACT participation in the current PAP.

Current linked October 2026 form lists these four medicines. CIMZIA has a product-specific exclusion for government-funded healthcare coverage. NAYZILAM prescriptions require an MD or DO signature under the form’s Texas-pharmacy instructions. Submit only requested material; the form prohibits additional or unrequested medical records. Individual eligibility remains subject to program review.

Published online application entry for the current PAP. The page loaded an application shell; authenticated enrollment and submission were not tested.

Page 4 lists the PAP pharmacy phone in the consent-to-receive-communications section. Its demonstrated purpose is questions about program communications; prescription, dispensing and refill routing are not established by this source.

Name the relevant program and authorization or communications request using that form’s instructions. Consolidated because all three reviewed programs publish the same privacy channels. BRIVIACT is not included in this PAP-derived product scope.

Both current brand pages publish this patient savings-program question and discontinuation line. Commercial-insurance restrictions and product-specific caps apply; a shared contact does not make the programs interchangeable.

Both brand pages place this number in their pharmacist instructions for secondary savings-card claims. Use the correct product’s current card and terms.

Published NEUPRO Patient Savings Program questions and discontinuation contact. Its terms restrict the savings card to eligible commercial coverage; PAP access uses the separate PAP application route.

Currently linked form is published January 2026. Fax completed enrollment and benefits-verification forms here. Full-service support includes copay/bridge enrollment, specialty-pharmacy routing and prior-authorization or appeal follow-up. Obtain required patient authorization; program support does not replace payer approval.

Current patient page identifies this Nurse Navigator contact for prescription-status and insurance-coverage support. The current form also uses it for communications questions. Navigator support does not provide medical advice.

Officially linked provider enrollment portal. Public retrieval returned an iAssist shell; login and processing were not tested.

Currently linked form is published May 2026. Fax the completed enrollment and benefits-verification form here for medical or pharmacy benefit verification and prior-authorization support. Required provider certification and patient authorization remain necessary.

CIMZIA Nurse Navigator support, including insurance and financial-support navigation. Navigators do not provide medical advice.

The current CIMZIA nurse-support page publishes this separate Spanish-language support number. Navigators do not provide medical advice.

Current brand page still links the ©2024 form. Submit required reimbursement materials and EOB or pharmacy receipt as directed. In-office lyophilized-powder claims require patient and administering-physician enrollment. The current brand page also directs savings-card processing problems to this phone. Program review determines eligible reimbursement.

Officially linked portal for CIMZIA office enrollment and program workflows. Public login page observed; no account or submission was used.

The current CIMZIA savings page publishes this number for uninsured patients seeking information about assistance. It is an information/referral line as published; the current UCB PAP application directs intake to 877-785-8906 with a separate fax and address.

Official UCB Direct page identifies KnippeRx Pharmacy as this BRIVIACT program’s pharmacy partner and publishes these prescription/access contacts. Limited to tablet or oral-solution prescriptions and residents of the continental United States including DC. Insurance review or discounted cash access is distinct from PAP enrollment; confirm terms with the program.

KnippeRx portal linked by the official UCB Direct BRIVIACT page. Its public page is an enrollment application shell; no information was entered. The same continental-US program limits apply.